Furthermore, SPRY4-AS1 expressions in surgical specimens were verified by RT-PCR and immunohistochemistry, revealing an association with survival in ACC, GBM, LGG, and MESO. This evidence concerns the gene SPRY4 and adrenal cortex carcinoma.